Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2020-03-02
2021-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Stimulation Therapy for Apnea Reduction (Www.theSTARtrial.Com)
NCT01161420
Obstructive Sleep Apnea Therapy by Stimulation of the Hypoglossal Nerve
NCT03844295
Predicting Outcomes in Hypoglossal Nerve Stimulation Therapy With Stimulated Upper Airway Mechanics
NCT05429983
Upper Airway Stimulation Versus Continuous Positive Airway Pressure
NCT03756805
Inspire® Upper Airway Stimulation (UAS) System German Post-Market Study
NCT02293746
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure
Patients with moderate to severe OSA treated with UAS (Inspire Medical Systems, Inc)
Upper airway stimulation (Inspire Medical Systems, Inc.)
phasic hypoglossal nerve stimulation device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Upper airway stimulation (Inspire Medical Systems, Inc.)
phasic hypoglossal nerve stimulation device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ADHERE registry patient
* Received UAS implant from June 2017 to present
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inspire Medical Systems, Inc.
INDUSTRY
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Faith Luyster
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Faith Luyster, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pittsburgh
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pittsburgh
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Luyster FS, Ni Q, Lee K, Harrison C, Ramprasad VH, Soose RJ, Strollo PJ. Factors affecting obstructive sleep apnea patients' use of upper airway stimulation treatment. J Clin Sleep Med. 2022 Sep 1;18(9):2207-2215. doi: 10.5664/jcsm.10086.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY20090150
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.